These differences were more noticeable for the SLC5A2 rs3813008 variant, an intronic tag-SNP that has been studied in relation to T2DM susceptibility and glycaemic parameters [14,58], but that to date was untested in the CKD setting. This evidence concerns the gene SLC5A2 and chronic kidney disease.